/SYNB
SYNB Stock - Putnam BioRevolution ETF
Financial Services|Asset ManagementAMEX
$31.61-0.37%
$0.12 (-0.37%) • Nov 13
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.67
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.77
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $34.77
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SYNB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$31.30 – $31.93
TARGET (TP)$36.35
STOP LOSS$29.08
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.07
52W High$31.73
52W Low$24.57
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
SYNBLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about SYNB
What is SYNB's current stock price?
Putnam BioRevolution ETF (SYNB) is currently trading at $31.61 per share. The stock has moved -0.37% today.
What is the analyst price target for SYNB?
No analyst price targets are currently available for this stock.
What sector is Putnam BioRevolution ETF in?
Putnam BioRevolution ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the AMEX exchange.
What is SYNB's market cap?
Putnam BioRevolution ETF has a market capitalization of $0.01 billion, making it a small-cap company.
Does SYNB pay dividends?
No, Putnam BioRevolution ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAWEG
Alger Weatherbie Enduring Growth ETF
$22.53
Mkt Cap: $0.0B
BWEB
Bitwise Web3 ETF
$72.72
Mkt Cap: $0.0B
EXUS
Macquarie Focused International Core ETF
$25.68
Mkt Cap: $0.0B
FRIZ
Franklin Dividend Growth ETF
$25.58
Mkt Cap: $0.0B
IPOS
Renaissance International IPO ETF
$16.79
Mkt Cap: $0.0B
ODDS
Pacer BlueStar Digital Entertainment ETF
$29.11
Mkt Cap: $0.0B
RVRB
Reverb ETF
$35.76
Mkt Cap: $0.0B
SEPI
Shelton Equity Premium Income ETF
$26.45
Mkt Cap: $0.0B
SPCZ
RiverNorth Enhanced Pre-Merger SPAC ETF
$28.68
Mkt Cap: $0.0B
UPGR
Xtrackers US Green Infrastructure Select Equity ETF
$24.85
Mkt Cap: $0.0B
Explore stocks similar to SYNB for comparison